Navigation Links
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Date:1/8/2009

tes from discovery into the clinic."

Principal investigator Osama Gaber, M.D., F.A.C.S. Director, Transplant Center of Excellence at The Methodist Hospital, Houston, Texas said, "Our clinical team is excited to participate in clinical trials that evaluate new therapies for renal transplant patients. Patients that develop DGF following renal transplantation have inferior kidney graft survival compared to those who do not. There is a real unmet medical need for a drug product to prevent DGF."

Daniel Zurr, Chief Executive Officer, commented, "We are very pleased to announce initiation of human dosing of the systemically administered QPI-1002 in our Phase I/II trial in kidney transplant patients. Furthermore, our siRNA drug candidate, PF-4523655, has been advanced into two Phase II clinical trials -- one for diabetic macular edema and the other for age related macular degeneration -- by our licensee, Pfizer. In addition, we recently announced that our QPI-1007 drug candidate, utilizing a novel siRNA structure developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent for eye diseases. These significant developments confirm the robustness of Quark's clinical pipeline and the strength of its capabilities in the RNAi arena."

Delayed graft function (DGF) is one of the most common complications during the immediate postoperative period in renal transplantation and affects 25-40% of the deceased donor renal transplants in the United States. DGF in renal transplantation results most often from ischemia-reperfusion injury that occurs when the blood flow is re-established to the transplanted kidney initiating a chain of events that can lead to severe renal damage upon transplantation. Post-kidney transplant DGF is associated with longer hospital stays and higher rates of graft rejection, which in turn decreases the survival of the transplanted kidney (graft survival). Current
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
2. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
5. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
6. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
9. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... N.Y. and PARIS , ... REGN)  and Sanofi have entered into a new ... cancer treatments in the emerging field of immuno-oncology. As ... develop a programmed cell death protein 1 (PD-1) inhibitor ... clinical trials in 2016 with new therapeutic candidates based ...
(Date:7/27/2015)... ATLANTA , July 27, 2015  SeraCare ... vitro diagnostics manufacturers, announced at the 2015 AACC ... strategic partnership agreement with ViveBio, LLC, a biotechnology ... based upon ViveST™ technology.  Products enabled with ViveST™ ... dried, shelf stable format.  Under the terms of ...
(Date:7/27/2015)... July 27, 2015  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Monday, ... Officer will lead the call. ... 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, including Replay ...
Breaking Medicine Technology:Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3
... BMRN ) will host a Research and Development ... from 8:00 a.m. to 12:00 p.m. at the St. Regis ... and outside experts will provide an update on the company,s ... Interested parties may access a live audio webcast ...
... N.J. , Oct. 5 Health Strategies ... pharmaceutical and biotechnology professionals, has launched a new ... provide essential insights into the complex institutional market, ... care facilities. Offering one-stop convenience, the services give ...
Cached Medicine Technology:BioMarin to Host a Research and Development Day on October 19th 2Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel 2Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel 3
(Date:7/28/2015)... ... 28, 2015 , ... Peter Forbes, President of the Veterans Fund of the United States, managing ... the Veterans Coalition, is spearheading a campaign to help homeless Veterans by giving them “A ... and trade skills. Forbes and the UVBH assists and supports Vets through the Veterans ...
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced ... Techniques to Improve the Quality of Investigations , **Presented by FDAnews and Learning ... and CAPAs have been the #1 reason for 483 observations since 1997! , ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women (NAPW) ... Woman of the Year Circle. She is recognized with this prestigious distinction for leadership ... is the nation’s leading networking organization exclusively for professional women. , “I’m pleased to ...
(Date:7/27/2015)... MA (PRWEB) , ... July 27, 2015 , ... ... has transformed the science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy ... the American Academy of Neurology (AAN). The FSHD care guideline is published today. ...
(Date:7/27/2015)... ... July 27, 2015 , ... North Central Surgical Center Hospital will be holding ... all those prospective joint-replacement patients, along with their friends and family members, to attend. ... classes (Aug 6, Sept 8 [Tue due to Labor Day], Oct 5, Nov 2, ...
Breaking Medicine News(10 mins):Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2
... , ... Reportlinker.com announces that a new market research report is ... , http://www.reportlinker.com/p0171106/Diet-Foods--2010-Edition.html , The diet foods market ... sectors. These have followed different growth paths. The old established ...
... American College of Physicians (ACP) has issued a ... physicians, and caregivers. The Journal of ... Patients and Physicians: Ethical Guidance to Optimize Relationships." ... to help physicians manage relationships with patients and ...
... fast-acting compound that appears to improve cognitive function impairments ... progressive Alzheimer,s disease has been identified by scientists at ... University Medical Center Program in Drug Discovery. Researchers hope ... The compound benzylquinolone carboxylic acid (BQCA) has ...
... , MOUNTAIN ... Inc. (Nasdaq: OMCL ), a leading provider of ... NewYork-Presbyterian Hospital has chosen Omnicell as its primary vendor ... safety of medications for our patients, we need a system that ...
... significantly, study finds , TUESDAY, Jan. 12 (HealthDay News) -- ... heart rate boosts the risk of dying from a heart ... Norwegian researchers tracked the health of about 50,000 healthy adults, ... During that time, 6,033 men and 4,442 women died. Heart ...
... ... announcing a new meal plan catering to vegetarian dieters. , ... (PRWEB) January 12, 2010 -- Diet-to-Go, a ... line of meals that can help millions of health-conscious Americans eat great, lose weight, ...
Cached Medicine News:Health News:Reportlinker Adds Diet Foods- 2010 Edition 2Health News:Reportlinker Adds Diet Foods- 2010 Edition 3Health News:Reportlinker Adds Diet Foods- 2010 Edition 4Health News:Reportlinker Adds Diet Foods- 2010 Edition 5Health News:Reportlinker Adds Diet Foods- 2010 Edition 6Health News:Reportlinker Adds Diet Foods- 2010 Edition 7Health News:Reportlinker Adds Diet Foods- 2010 Edition 8Health News:Reportlinker Adds Diet Foods- 2010 Edition 9Health News:Reportlinker Adds Diet Foods- 2010 Edition 10Health News:Reportlinker Adds Diet Foods- 2010 Edition 11Health News:Reportlinker Adds Diet Foods- 2010 Edition 12Health News:Reportlinker Adds Diet Foods- 2010 Edition 13Health News:Reportlinker Adds Diet Foods- 2010 Edition 14Health News:New ethical guidance from ACP for patient-physician-caregiver relationship 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 3Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 2Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 3Health News:NewYork-Presbyterian Hospital Selects Omnicell for Medication Management 4Health News:Faster Heart Rate May Raise Risk of Heart Attack Death 2Health News:Diet-to-Go Delivers Deliciously Healthy Vegetarian Meals 2
... AlphaPette Pipettor is the #1 Pipettor ... accuracy, comfort, and reliability. Continuously adjustable. ... readout sub-micrometer. Easy interchangeable ejector buttons ... hands. Adjustable rapid pipet tip ejector ...
... Digital offers improved ergonomics for today's ... modified grippy finger rest and the ... and efficiency. Finnpipette Digitals also feature ... mechanism (pat. pend.) and super blow-out ...
The Leader in ICU Humidification., ,Available Configurations: , Gas Sampling Port, Straight Flex Tube, Poppel Flex Tube, Luer Port for Pressure, Monitoring/Secretion Removal, Special Use Devices, M...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
Medicine Products: